Light Exposure, Migraine Outcomes, and Sleep Quality
Daily Light Exposure Patterns and Their Associations With Migraine Outcomes and Sleep Quality
1 other identifier
interventional
20
1 country
1
Brief Summary
The purpose of this study is to examine the relationship between daily light exposure patterns, sleep quality, and migraine characteristics in adults with migraine, with and without photophobia, across an 8-week study period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 8, 2026
CompletedFirst Posted
Study publicly available on registry
March 17, 2026
CompletedStudy Start
First participant enrolled
March 24, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
April 28, 2026
April 1, 2026
11 months
March 8, 2026
April 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Monthly Migraine Days
Number of migraine days per 28-day period as recorded in daily electronic headache diaries. A migraine day is defined as a calendar day with a self-reported migraine meeting International Classification of Headache Disorders (ICHD-3) criteria. The primary analysis will compare the 4-week baseline period to the 4-week intervention period within participants.
Baseline (Weeks 1-4) compared to Intervention (Weeks 5-8)
Secondary Outcomes (7)
Change in Migraine Headache Intensity
Baseline (Weeks 1-4) compared to Intervention (Weeks 5-8)
Change in Migraine-Specific Quality of Life (MSQ v2.1) Score
Baseline (Week 0), Between Baseline and Intervention (end of Week 4), and End of Intervention (Week 8).
Change in Objective Sleep Efficiency
Baseline (Weeks 1-4) compared to Intervention (Weeks 5-8)
Change in Average Daily Ambient Light Intensity
Baseline (Weeks 1-4) compared to Intervention (Weeks 5-8)
Feasibility of Workplace Lighting Intervention
Intervention Period (Weeks 5-8)
- +2 more secondary outcomes
Study Arms (1)
Optimized Lighting Intervention
EXPERIMENTALAll participants will complete a 4-week baseline observation period followed by a 4-week intervention period. During the baseline period, daily light exposure, sleep, and migraine characteristics will be monitored under natural conditions. During the intervention period, participants will use an optimized workplace lighting condition during working hours while continuing wearable monitoring and daily electronic surveys. Outcomes during the intervention period will be compared to baseline measurements within participants.
Interventions
Application of an optimized ambient lighting condition through placement of a dimmable LED floor lamp in participants' private workspaces to create a standardized workplace lighting environment during working hours. The floor lamp emits white light with a specified spectral distribution and intensity. Participants may adjust brightness for comfort. The lighting system is used solely to modify the ambient workplace lighting environment during the 4-week intervention period.
Eligibility Criteria
You may qualify if:
- Meet the International Classification of Headache Disorders, 3rd edition (2018) criteria for migraine, with or without aura or photosensitivity
- Report experiencing more than 4 headache days per month and at least three migraine attacks per month
- No other major health issues based on self-reported data
- Able to read and communicate in English
- Work in a private office space for at least six hours per day, four days per week
You may not qualify if:
- Light therapy
- Use light-altering devices (e.g., blue-blocking contact lenses or glasses)
- Traveling out of town during the participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Flinn Foundationcollaborator
- Arizona State Universitylead
Study Sites (1)
ASU DeSmart Lab
Tempe, Arizona, 85281, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nina Sharp, PhD
Arizona State University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
March 8, 2026
First Posted
March 17, 2026
Study Start
March 24, 2026
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
March 1, 2027
Last Updated
April 28, 2026
Record last verified: 2026-04